newsfilter
← Latest News
ACCESS Newswire·

Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22

SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing innovative medicines